跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
趙 興隆
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0003-2957-1686
電子郵件
109088
w.tmu.edu
tw
h-index
883
引文
18
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2001
2022
每年研究成果
概覽
指紋
網路
研究成果
(41)
資料集
(16)
類似的個人檔案
(9)
指紋
查看啟用 HsingLung Chao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Radiation Therapy
100%
Hepatocellular Carcinoma
53%
Intensity Modulated Radiation Therapy
38%
Neoplasm
36%
Radiation Therapy
26%
Nasopharynx Carcinoma
26%
Cohort Analysis
26%
Overall Survival
22%
Cyberknife
21%
Stereotactic Body Radiation Therapy
20%
Breast Cancer
20%
Survival Rate
18%
Hepatic Portal Vein
16%
Head and Neck Cancer
15%
Computer Assisted Tomography
14%
Conformal Radiotherapy
13%
Radiomics
13%
Prostate Cancer
13%
Prognostic Factor
12%
Volumetric Modulated Arc Therapy
11%
Malignant Neoplasm
11%
Diseases
11%
Tumor Thrombus
10%
Vascular Tissue Neoplasm
10%
Treatment Response
9%
Drug Megadose
8%
Hazard Ratio
8%
Chemoradiotherapy
8%
Cancer Risk
7%
Recurrent Disease
7%
Breast Radiotherapy
6%
Spinal Cord Lesion
6%
Skin Surface
6%
Biological Marker
6%
Analgesia
6%
Stereotactic Radiosurgery
6%
Brain Necrosis
6%
Visual Analog Scale
6%
Radiosensitivity
6%
Immunotherapy
6%
Lung Tumor
6%
Germinoma
6%
Pancreas Cancer
6%
Basal Ganglia
6%
Tonsil Carcinoma
6%
Clear Cell Renal Cell Carcinoma
6%
Squamous Cell Carcinoma
6%
Adjuvant Radiotherapy
6%
Urinary Tract Infection
6%
Intraoperative Radiation Therapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
26%
Overall Survival
22%
Malignant Neoplasm
22%
Nasopharynx Carcinoma
20%
Liver Cell Carcinoma
20%
Survival Rate
14%
Chemotherapy
14%
Breast Cancer
13%
Prostate Cancer
13%
Neoplasm
13%
Recurrent Disease
11%
Chemoradiation Therapy
8%
Head and Neck Cancer
8%
Diseases
8%
Brain Necrosis
6%
Lung Tumor
6%
Pancreas Cancer
6%
Spinal Cord Lesion
6%
Cellular Injury
6%
Polyethylene Terephthalate
6%
Tonsil Carcinoma
6%
Migraine
6%
Brain Edema
6%
Squamous Cell Carcinoma
6%
Urinary Tract Infection
6%
Hypothyroidism
6%
Optic Nerve Disease
6%
Intracranial Tumor
6%
Rhodiola crenulata
6%
Bilirubin
6%
Fluorodeoxyglucose F 18
6%
Tissue Necrosis
6%
Hypopharynx Cancer
6%
Necrosis
5%
Disease Free Survival
5%